HealthcareAI Research5 min reading time

🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

Latent.Space
Read full post
At the 2026 JPM Pharma conference, Chai Discovery, backed by OpenAI and valued at $4B, emerged as a key player in AI-powered drug discovery tools. Their advancements have reached a trust level enabling pharma teams to scale and innovate drug design, including complex antibody engineering.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI